Pennant Investors »

Arcus Biosciences Incorporated shares owned by Pennant Investors

Quarter-by-quarter ownership of Arcus Biosciences Incorporated (RCUS) shares owned by Pennant Investors from 13F filings

Historical chart of Pennant Investors investment in Arcus Biosciences Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Arcus Biosciences Incorporated held by Pennant Investors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arcus Biosciences Incorporated by Pennant Investors

Quarter filed Position value Share count Share price at filing
2024-03-31 $448k 24k 18.88

More positions owned by Pennant Investors

Amazon (AMZN)
TransDigm Group Incorporated (TDG)
Antero Res Call Option (AR)
Microsoft Corporation (MSFT)
Micron Technology (MU)
Echostar Corp Cl A (SATS)
Alphabet Cap Stk Cl A (GOOGL)
Apple Put Option (AAPL)
Colfax Corp (ENOV)
ODP Corp. (ODP)
Perimeter Solutions Sa Common Stock (PRM)
Fibrogen (FGEN)
Arcutis Biotherapeutics (ARQT)
Altimmune Com New (ALT)
Fate Therapeutics (FATE)

View all positions for Pennant Investors

Top funds holding Arcus Biosciences Incorporated

BlackRock
BlackRock
Vanguard Group
Woodline Partners
State Street Corporation
Point72 Asset Management
Siren
Invus Financial Advisors
Boxer Capital
Dimensional Fund Advisors
Alliancebernstein
Geode Capital Management
Suvretta Capital Management
Bnp Paribas Investment Partners
Decheng Capital

View all funds holding Arcus Biosciences Incorporated